People on the Move: July 2020
Our latest spotlight on new hires, promotions and awards involves Lonza, ChargePoint Technology, Ashfield, Current Health and other industry firms.
Archives for July 2, 2020
Noxopharm launches Phase I COVID-19 program in Europe
The drug development firm is exploring the viability of Veyonda as a potential treatment for cytokine storm and septic shock in diagnosed patients.
This week’s FDA COVID-19 news
The agency continues to offer advice for drug developers and other stakeholders, and to take action against companies that step out of line.